
Silence Therapeutics (SLN) Market Capitalization Overview
Market Cap: $228.62M as of Feb 3, 2026
$228.62M
$61.88M (21.30%)past month
As of Feb 3, 2026, Silence Therapeutics (SLN) has a market capitalization of $228.62M. Over the past 30 days, its market cap has decreased by -20.33%, while in the last 12 months, it has decreased by -20.39%.
Market capitalization represents the total value of Silence Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Silence Therapeutics (SLN) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Silence Therapeutics (SLN) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Silence Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Silence Therapeutics (SLN) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Silence Therapeutics (SLN) helps investors assess the company's size and compare it with competitors for better investment decisions.
Silence Therapeutics (SLN) Market Cap & Key Trends
See Silence Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Silence Therapeutics (SLN)
Order type
Buy in
Order amount
Est. shares
0 shares
Silence Therapeutics (SLN) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $311.28M | -0.30% |
| Nov 3, 2025 | $312.22M | +29.61% |
| Oct 1, 2025 | $240.90M | +6.92% |
| Sep 2, 2025 | $225.31M | -22.68% |
| Aug 1, 2025 | $291.42M | +4.22% |
| Jul 1, 2025 | $279.61M | +3.32% |
| Jun 2, 2025 | $270.63M | +42.91% |
| May 1, 2025 | $189.38M | +65.70% |
| Apr 1, 2025 | $114.29M | -43.98% |
| Mar 3, 2025 | $204.02M | -14.61% |
| Feb 3, 2025 | $238.91M | -29.62% |
| Jan 2, 2025 | $339.48M | -12.10% |
Silence Therapeutics (SLN) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $228.62M | -20.39% |
| 2025 | $287.19M | -11.59% |
| 2024 | $324.84M | -51.64% |
| 2023 | $671.70M | +47.17% |
| 2022 | $456.41M | -36.17% |
| 2021 | $714.99M | — |
FAQs About Silence Therapeutics (SLN) Market Cap
As of Feb 3, 2026, the market capitalization of Silence Therapeutics (SLN) is $228.62M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Silence Therapeutics’s market capitalization has decreased by -21.30%, changing from $290.49M to $228.62M as of Feb 3, 2026.
In the last 3 months, Silence Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Silence Therapeutics’s market capitalization decreased from $324.84M in January to $287.19M in December, reflecting a -11.59% change.
In the past five years, Silence Therapeutics (SLN) has had a compound annual growth rate (CAGR) of -16.68% in market capitalization. This means its market cap has shrunk at an average rate of -16.68% per year.